×
Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Food Allergy Diagnosis Treatment Market Trends

ID: MRFR/HC/6093-CR
123 Pages
Rahul Gotadki
March 2019

Food Allergy Diagnosis and Treatment Market Research Report By Diagnosis Method (Skin Prick Test, Blood Test, Oral Food Challenge, Elimination Diet), By Treatment Type (Medication, Immunotherapy, Dietary Management, Emergency Treatment Devices), By End User (Hospitals, Clinics, Home Care, Pharmaceutical Companies), By Age Group (Children, Adults, Elderly) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Food Allergy Diagnosis Treatment Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Market Trends

Key Emerging Trends in the Food Allergy Diagnosis Treatment Market

The market trends of the food allergy diagnosis and treatment market have been witnessing significant evolution and growth in recent years. With an increasing prevalence of food allergies globally, the demand for accurate diagnosis and effective treatment options has surged, driving innovation and investment in this sector.

One prominent trend in the food allergy diagnosis market is the development of advanced diagnostic technologies. Traditional methods for diagnosing food allergies, such as skin prick tests and blood tests, are being complemented by newer, more precise techniques like component-resolved diagnostics (CRD) and molecular testing. These advanced diagnostic tools offer healthcare providers and patients greater insights into specific allergens, helping to tailor treatment plans and improve patient outcomes.

Furthermore, there is a growing emphasis on improving the accessibility and affordability of food allergy testing. As awareness of food allergies increases, more individuals are seeking testing services, leading to a greater demand for convenient and cost-effective diagnostic solutions. Companies in the market are responding by developing point-of-care testing devices and expanding distribution networks to reach a wider patient population.

In addition to diagnostics, the treatment landscape for food allergies is also undergoing significant transformation. Historically, avoidance of allergenic foods and emergency management of allergic reactions were the primary strategies for managing food allergies. However, there is now a growing focus on developing immunotherapy-based treatments that aim to desensitize patients to specific allergens.

Immunotherapy, which includes oral immunotherapy (OIT), sublingual immunotherapy (SLIT), and epicutaneous immunotherapy (EPIT), has shown promise in clinical trials for reducing allergic reactions and improving quality of life for patients with food allergies. These treatments work by gradually exposing patients to increasing doses of allergens, helping to build tolerance over time.

Another emerging trend in the food allergy treatment market is the development of biologic therapies targeting key pathways involved in allergic responses. Monoclonal antibodies that block specific immune mediators, such as immunoglobulin E (IgE), have demonstrated efficacy in reducing the severity of allergic reactions in patients with severe food allergies. These biologic therapies represent a novel approach to managing food allergies and offer new hope for patients with limited treatment options.

Moreover, the regulatory landscape surrounding food allergy diagnosis and treatment is evolving to ensure the safety and efficacy of new products entering the market. Regulatory agencies are working closely with industry stakeholders to establish clear guidelines for clinical trials, product approval, and post-market surveillance of food allergy diagnostics and treatments. This collaborative approach aims to foster innovation while safeguarding patient health and well-being.

Overall, the food allergy diagnosis and treatment market is poised for continued growth and innovation in the coming years. With advances in diagnostic technologies, novel treatment modalities, and supportive regulatory frameworks, healthcare providers and patients alike can expect to see improved outcomes and quality of life for individuals living with food allergies. As research continues to unravel the complexities of food allergies, the market is likely to see further advancements that will shape the future of allergy care and management.

Author
Rahul Gotadki
Research Manager

He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

Get In Touch

Leave a Comment

FAQs

What is the current valuation of the food allergy diagnosis and treatment market?

<p>The market valuation was 32.5 USD Billion in 2024.</p>

What is the projected market size for the food allergy diagnosis and treatment market by 2035?

<p>The market is projected to reach 55.7 USD Billion by 2035.</p>

What is the expected CAGR for the food allergy diagnosis and treatment market during the forecast period?

<p>The expected CAGR for the market from 2025 to 2035 is 5.02%.</p>

Which companies are considered key players in the food allergy diagnosis and treatment market?

<p>Key players include Thermo Fisher Scientific, Abbott Laboratories, Danone, Nestle, Bayer AG, Mylan N.V., Aimmune Therapeutics, Allergan, and Horizon Therapeutics.</p>

What are the main applications in the food allergy diagnosis and treatment market?

<p>Main applications include Skin Testing, Blood Testing, Oral Food Challenge, and Patch Testing.</p>

How much revenue is generated from blood testing in the food allergy diagnosis and treatment market?

<p>Blood Testing generated revenues of 10.0 USD Billion in 2024 and is projected to reach 16.0 USD Billion by 2035.</p>

What is the revenue outlook for hospitals as an end-use segment in the food allergy diagnosis and treatment market?

<p>Hospitals generated 10.0 USD Billion in 2024 and are expected to reach 17.0 USD Billion by 2035.</p>

Which type of allergy generates the highest revenue in the market?

<p>Shellfish Allergy generated 10.5 USD Billion in 2024 and is projected to reach 19.4 USD Billion by 2035.</p>

What are the projected revenues for specific IgE testing by 2035?

<p>Specific IgE Testing is expected to generate revenues of 10.2 USD Billion in 2024 and reach 17.0 USD Billion by 2035.</p>

How does the food allergy diagnosis and treatment market's growth compare across different diagnosis methods?

<p>The market for diagnosis methods shows varied growth, with Skin Prick Test projected to grow from 8.1 USD Billion in 2024 to 13.5 USD Billion by 2035.</p>

Market Summary

As per Market Research Future analysis, the Food Allergy Diagnosis and Treatment Market was estimated at 1.72 USD Billion in 2024. The Food Allergy Diagnosis and Treatment industry is projected to grow from 1.851 USD Billion in 2025 to 3.851 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 7% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The Food Allergy Diagnosis and Treatment Market is experiencing robust growth driven by technological advancements and increasing consumer awareness.

  • Technological advancements in diagnostics are enhancing the accuracy and speed of food allergy testing, particularly in North America. Consumer awareness regarding food allergies is rising, leading to increased demand for effective diagnosis and treatment options in the Asia-Pacific region. The Skin Prick Test remains the largest segment, while Blood Tests are emerging as the fastest-growing diagnostic method. Rising prevalence of food allergies and advancements in diagnostic technologies are key drivers propelling market growth.

Market Size & Forecast

2024 Market Size 1.72 (USD Billion)
2035 Market Size 3.851 (USD Billion)
CAGR (2025 - 2035) 7.6%
Largest Regional Market Share in 2024 North America

Major Players

<a href="https://www.thermofisher.com/content/diagnostics/phadia/global/en-wo/our-solutions/immunocap-allergy-solutions.html">Thermo Fisher Scientific</a> (US), Abbott Laboratories (US), Danone (FR), Nestle (CH), Bayer AG (DE), Mylan N.V. (US), Aimmune Therapeutics (US), Allergan (IE), Horizon Therapeutics (IE)

Market Trends

The Food Allergy Diagnosis and Treatment Market is currently experiencing a notable evolution, driven by increasing awareness of food allergies and their potential health implications. As more individuals recognize the importance of accurate diagnosis and effective management, the demand for innovative diagnostic tools and treatment options appears to be on the rise. This market encompasses a range of products and services, including skin tests, blood tests, and various therapeutic interventions aimed at alleviating symptoms and improving quality of life for those affected. Furthermore, advancements in technology and research are likely to enhance the precision of diagnostic methods, thereby facilitating timely and appropriate treatment strategies. In addition to technological advancements, the Food Allergy Diagnosis and Treatment Market is influenced by changing dietary habits and lifestyle choices. As consumers become more health-conscious, there is a growing emphasis on understanding food ingredients and their potential allergenic properties. This trend may lead to increased collaboration between healthcare providers, food manufacturers, and regulatory bodies to ensure safer food options for individuals with allergies. Overall, the market appears poised for growth, with a focus on enhancing patient outcomes through improved diagnostic and therapeutic solutions.

Technological Advancements in Diagnostics

Recent innovations in diagnostic technologies are transforming the Food Allergy Diagnosis and Treatment Market. Enhanced methods, such as molecular testing and next-generation sequencing, are likely to provide more accurate and rapid identification of allergens. These advancements may lead to better patient management and tailored treatment plans.

Increased Consumer Awareness

There is a noticeable rise in consumer awareness regarding food allergies, which is influencing the Food Allergy Diagnosis and Treatment Market. As individuals become more informed about the risks associated with food allergies, they are more likely to seek diagnostic services and effective treatment options, thereby driving market growth.

Regulatory Changes and Food Safety

Regulatory bodies are increasingly focusing on food safety standards, which impacts the Food Allergy Diagnosis and Treatment Market. Stricter regulations regarding labeling and allergen management may encourage food manufacturers to develop safer products, ultimately benefiting consumers with food allergies.

Food Allergy Diagnosis Treatment Market Market Drivers

Rising Healthcare Expenditure

The increasing healthcare expenditure across various regions is likely to bolster the Food Allergy Diagnosis and Treatment Market. As healthcare systems allocate more resources to allergy management, there is a corresponding rise in funding for research and development of new diagnostic and therapeutic solutions. This trend is particularly evident in countries with advanced healthcare infrastructures, where investments in allergy clinics and specialized training for healthcare professionals are becoming more common. The growing recognition of food allergies as a public health concern is prompting governments and private sectors to prioritize funding for effective management strategies. As a result, the Food Allergy Diagnosis and Treatment Market is poised for growth, driven by enhanced access to care and improved treatment options.

Rising Prevalence of Food Allergies

The increasing prevalence of food allergies among various populations appears to be a primary driver for the Food Allergy Diagnosis and Treatment Market. Recent studies indicate that food allergies affect approximately 8% of children and 4% of adults, leading to a heightened demand for effective diagnostic tools and treatment options. This growing incidence necessitates advancements in allergy testing methodologies and therapeutic interventions, thereby propelling market growth. As awareness of food allergies expands, healthcare providers are increasingly focused on developing comprehensive management strategies, which further stimulates the Food Allergy Diagnosis and Treatment Market. The rising number of allergic reactions and anaphylaxis cases underscores the urgency for innovative solutions, suggesting that the market will continue to evolve in response to these pressing health concerns.

Advancements in Diagnostic Technologies

Technological innovations in diagnostic tools are significantly influencing the Food Allergy Diagnosis and Treatment Market. The introduction of novel testing methods, such as component-resolved diagnostics and molecular allergology, enhances the accuracy and efficiency of food allergy identification. These advancements allow for more precise allergen profiling, which is crucial for effective treatment planning. Moreover, the integration of artificial intelligence and machine learning in diagnostic processes is expected to streamline patient assessments and improve outcomes. As these technologies become more accessible, healthcare providers are likely to adopt them, thereby expanding the market. The potential for rapid and reliable testing solutions may lead to increased patient compliance and satisfaction, further driving the Food Allergy Diagnosis and Treatment Market.

Growing Demand for Personalized Medicine

The shift towards personalized medicine is emerging as a significant driver in the Food Allergy Diagnosis and Treatment Market. Patients increasingly seek tailored treatment plans that consider their unique genetic and environmental factors. This trend is prompting healthcare professionals to explore individualized approaches to allergy management, including targeted immunotherapy and customized dietary recommendations. The market is witnessing a rise in research focused on understanding the genetic basis of food allergies, which could lead to more effective interventions. As personalized treatment options gain traction, the Food Allergy Diagnosis and Treatment Market is likely to experience substantial growth, reflecting the evolving expectations of patients and healthcare providers alike.

Increased Regulatory Focus on Food Safety

The heightened regulatory scrutiny surrounding food safety is playing a crucial role in shaping the Food Allergy Diagnosis and Treatment Market. Governments and health organizations are implementing stricter guidelines to ensure the safety of food products, particularly for individuals with allergies. This regulatory environment encourages food manufacturers to adopt allergen labeling practices and invest in allergen-free product development. Consequently, the demand for reliable diagnostic tools and treatment options is expected to rise as consumers become more vigilant about food safety. The emphasis on compliance with food safety regulations may drive innovation within the Food Allergy Diagnosis and Treatment Market, as stakeholders seek to meet the evolving needs of allergic consumers.

Market Segment Insights

By Application: Skin Testing (Largest) vs. Blood Testing (Fastest-Growing)

<p>In the food allergy diagnosis and treatment market, Skin Testing is recognized as the largest application, capitalizing on its widespread acceptance and reliability in identifying specific allergies. It holds a significant portion of the market share, attributable to its minimal invasiveness and rapid results, making it a preferred choice for both clinicians and patients. Conversely, Blood Testing is witnessing rapid growth as technological advancements enhance its accuracy and efficiency. This method is becoming increasingly popular due to its ability to be conducted without skin exposure, appealing especially to patients with skin conditions or those who are hesitant about invasive procedures.</p>

<p>Skin Testing (Dominant) vs. Blood Testing (Emerging)</p>

<p>Skin Testing is well-established in the food allergy diagnosis market, known for its ease of use and rapid result delivery. It provides immediate feedback on IgE-mediated allergies, making it a dominant choice in clinical settings. Blood Testing, while traditionally viewed as a secondary option, is emerging with innovations that improve its foretelling of allergic responses. It is preferred by a segment of patients seeking a non-invasive alternative. As awareness around food allergies grows, the reliability and safety profile of both testing methods play critical roles in shaping their market positions, influencing practitioner recommendations and patient choices.</p>

By End Use: Hospitals (Largest) vs. Diagnostic Laboratories (Fastest-Growing)

<p>In the food allergy diagnosis and treatment market, hospitals represent the largest segment, utilizing advanced facilities and specialized staff to provide comprehensive care for patients with food allergies. Diagnostic laboratories, while currently smaller in market share, are emerging rapidly due to increased demand for precision testing and quicker results. Home care settings are gaining traction as more patients prefer flexible treatment options, while research institutions are vital for advancing the understanding of food allergies and developing new therapies.</p>

<p>Hospitals: (Dominant) vs. Diagnostic Laboratories (Emerging)</p>

<p>Hospitals are the dominant force in the food allergy diagnosis and treatment market, providing a wide range of services that include diagnostic tests, treatment plans, and patient management programs. Their integration of state-of-the-art technology and multidisciplinary teams guarantees high-quality care, resulting in better patient outcomes and satisfaction. In contrast, diagnostic laboratories are emerging as key players, fueled by innovations in testing methodologies and a growing awareness of food allergies. Their ability to deliver accurate and rapid allergy testing services is attracting both healthcare professionals and patients, making them an indispensable part of the food allergy management continuum.</p>

By Type of Allergy: Peanut Allergy (Largest) vs. Milk Allergy (Fastest-Growing)

<p>In the food allergy diagnosis and treatment market, the segment distribution showcases that peanut allergies represent the largest share, largely attributed to their high prevalence and the significant health complications associated with them. Milk allergies, on the other hand, while smaller in prevalence compared to peanut allergies, have been gaining ground due to rising awareness and better diagnostic tools, driving their share in the market.</p>

<p>Peanut Allergy (Dominant) vs. Milk Allergy (Emerging)</p>

<p>The peanut allergy segment is characterized by its well-established market presence, given the intensity of allergic reactions and the strict dietary restrictions required for management. It has dominated the food allergy sector for years, fueling a steady demand for diagnostics and therapeutic options. Conversely, the milk allergy segment is rapidly emerging, propelled by increased recognition of lactose intolerance and other dairy-related allergies. The growth in this area is supported by advancements in allergy testing technologies and a higher willingness among consumers to seek medical advice, which in turn encourages more effective treatment options.</p>

By Diagnosis Method: Skin Prick Test (Largest) vs. Specific IgE Testing (Fastest-Growing)

<p>Within the food allergy diagnosis market, the Skin Prick Test currently holds the largest market share, as it is a widely accepted and reliable method for diagnosing various food allergies. On the other hand, Specific IgE Testing is quickly gaining traction, particularly due to its advantages in assessing a broader range of allergens and providing more precise results. The increasing awareness of food allergies among healthcare professionals and patients is further driving the adoption of these diagnostic methods.</p>

<p>Skin Prick Test (Dominant) vs. Specific IgE Testing (Emerging)</p>

<p>The Skin Prick Test remains the dominant diagnostic method in the food allergy arena due to its proven efficacy, simplicity, and cost-effectiveness. As a traditional method, it allows for the rapid identification of potential allergic reactions by introducing small amounts of allergens into the skin. On the other hand, Specific IgE Testing is an emerging method that offers significant growth potential as it enhances allergen specificity and quantification. Patients and healthcare providers increasingly prefer this method for its precision in diagnosing allergies, which is critical for effective management of allergic conditions.</p>

Get more detailed insights about Food Allergy Diagnosis & Treatment Market Research Report – Global Forecast till 2035

Regional Insights

The Global Food Allergy Diagnosis and Treatment Market shows substantial growth potential, with North America leading the region with a market value of 3.2 USD Billion in 2024 and projected to reach 6.6 USD Billion by 2035. This region's dominance is attributed to advanced healthcare infrastructure and heightened awareness of food allergies among consumers. Europe follows, with a market value of 2.45 USD Billion in 2024 and an expected increase to 4.9 USD Billion by 2035, driven by stringent regulations and robust Research and Development initiatives.

The Asia-Pacific (APAC) region, valued at 1.5 USD Billion in 2024 and anticipated to double to 3.2 USD Billion by 2035, presents significant growth opportunities due to rising disposable incomes and increasing prevalence of food allergies. South America, with a market value of 0.5 USD Billion in 2024, is set to grow to 1.1 USD Billion by 2035, demonstrating a growing recognition of food allergy issues. 

Meanwhile, the Middle East and Africa (MEA) region remains smaller, starting at 0.16 USD Billion in 2024 and projected to reach 0.3 USD Billion by 2035, yet it signifies an emerging market ripe for development in allergy awareness and management.Overall, the Global Food Allergy Diagnosis and Treatment Market segmentation reflects varied regional strengths and indicates potential for improvement and innovation across all areas.

Key Players and Competitive Insights

The Global Food Allergy Diagnosis and Treatment Market has been witnessing substantial growth due to the increasing prevalence of food allergies globally. As awareness of food allergies has grown, there has been a surge in demand for innovative diagnostic tools and effective treatments. The market is characterized by a competitive landscape featuring several key players, each striving to enhance their market position through innovative product offerings, strategic collaborations, and advanced technologies. Companies in this sector are focusing on clinical research and the development of new therapeutic options to address the unique needs of patients suffering from food allergies. 
The competitive dynamics of this market are not only shaped by product innovation and technological advancements but also by regulatory factors and shifts in healthcare paradigms globally.Horizon Therapeutics has emerged as a significant player within the Global Food Allergy Diagnosis and Treatment Market, with a strong focus on innovative therapeutics aimed at improving patient outcomes. The company is recognized for its commitment to addressing unmet medical needs in food allergy management. Horizon Therapeutics leverages a robust research and development framework to create products that are not only effective but also align with evolving healthcare standards. 
Their strategic partnerships and collaborations have enhanced their market presence, enabling them to capitalize on new opportunities within this niche segment. The company’s strengths lie in its ability to navigate regulatory landscapes effectively, ensuring that its offerings are compliant and safe for patient use.Abbott Laboratories holds a prominent position in the Global Food Allergy Diagnosis and Treatment Market through its wide range of diagnostic tools and management solutions designed for food allergies. 
The company’s key products include advanced testing kits that enable accurate and timely diagnosis, facilitating better management of food allergies. Abbott Laboratories is known for its strong global presence, backed by innovative research and a commitment to improving patient health outcomes. Their strategic focus on expanding their product portfolio through mergers and acquisitions has further solidified their stance in the market. By continually investing in cutting-edge technology and maintaining strong relationships with healthcare providers, Abbott Laboratories showcases a solid foundation for growth and resilience in the highly competitive landscape of food allergy diagnosis and treatment globally.

Key Companies in the Food Allergy Diagnosis Treatment Market include

Industry Developments

Recent developments in the Global Food Allergy Diagnosis and Treatment Market have highlighted significant advancements and market shifts. Companies such as Aimmune Therapeutics, which focuses on therapies for peanut allergies, have gained attention for their innovative approaches, while Nestle is actively investing in Research and Development for allergy-friendly food products. Abbott Laboratories has introduced new diagnostic tools that enhance the accuracy of food allergy detection. In addition, the market has witnessed notable mergers and acquisitions; for instance, in March 2023, Unilever announced the acquisition of a prominent allergy-focused food brand, strengthening its portfolio in allergy-sensitive offerings. 

In January 2023, Horizon Therapeutics expanded its market reach by acquiring a biopharmaceutical company specializing in immunotherapies. Growth in this market is being driven by increased consumer awareness and the rising prevalence of food allergies globally, making it a lucrative sector for investments. The market is projected to grow substantially, with major players like Thermo Fisher Scientific and Mylan enhancing their diagnostic capabilities to meet rising demands. Over the last few years, approvals for several new allergy treatments have further contributed to market dynamics, attracting interest from investors and emerging companies alike.

Future Outlook

Food Allergy Diagnosis Treatment Market Future Outlook

The Food Allergy Diagnosis and Treatment Market is projected to grow at a 7.6% CAGR from 2025 to 2035, driven by increasing prevalence of food allergies and advancements in diagnostic technologies.

New opportunities lie in:

  • Development of personalized allergy immunotherapy solutions
  • Expansion of telehealth services for remote allergy consultations
  • Integration of AI-driven diagnostic tools in clinical settings

By 2035, the market is expected to be robust, driven by innovation and increased consumer awareness.

Market Segmentation

Food Allergy Diagnosis Treatment Market End User Outlook

  • Hospitals
  • Clinics
  • Home Care
  • Pharmaceutical Companies

Food Allergy Diagnosis Treatment Market Age Group Outlook

  • Children
  • Adults
  • Elderly

Food Allergy Diagnosis Treatment Market Treatment Type Outlook

  • Medication
  • Immunotherapy
  • Dietary Management
  • Emergency Treatment Devices

Food Allergy Diagnosis Treatment Market Diagnosis Method Outlook

  • Skin Prick Test
  • Blood Test
  • Oral Food Challenge
  • Elimination Diet

Report Scope

MARKET SIZE 2024 1.72(USD Billion)
MARKET SIZE 2025 1.851(USD Billion)
MARKET SIZE 2035 3.851(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 7.6% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Thermo Fisher Scientific (US), Abbott Laboratories (US), Danone (FR), Nestle (CH), Bayer AG (DE), Mylan N.V. (US), Aimmune Therapeutics (US), Allergan (IE), Horizon Therapeutics (IE)
Segments Covered Diagnosis Method, Treatment Type, End User, Age Group, Regional
Key Market Opportunities Advancements in personalized medicine enhance diagnostic accuracy in the Food Allergy Diagnosis and Treatment Market.
Key Market Dynamics Rising consumer awareness drives demand for innovative food allergy diagnostic tools and personalized treatment options.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the current valuation of the food allergy diagnosis and treatment market?

<p>The market valuation was 32.5 USD Billion in 2024.</p>

What is the projected market size for the food allergy diagnosis and treatment market by 2035?

<p>The market is projected to reach 55.7 USD Billion by 2035.</p>

What is the expected CAGR for the food allergy diagnosis and treatment market during the forecast period?

<p>The expected CAGR for the market from 2025 to 2035 is 5.02%.</p>

Which companies are considered key players in the food allergy diagnosis and treatment market?

<p>Key players include Thermo Fisher Scientific, Abbott Laboratories, Danone, Nestle, Bayer AG, Mylan N.V., Aimmune Therapeutics, Allergan, and Horizon Therapeutics.</p>

What are the main applications in the food allergy diagnosis and treatment market?

<p>Main applications include Skin Testing, Blood Testing, Oral Food Challenge, and Patch Testing.</p>

How much revenue is generated from blood testing in the food allergy diagnosis and treatment market?

<p>Blood Testing generated revenues of 10.0 USD Billion in 2024 and is projected to reach 16.0 USD Billion by 2035.</p>

What is the revenue outlook for hospitals as an end-use segment in the food allergy diagnosis and treatment market?

<p>Hospitals generated 10.0 USD Billion in 2024 and are expected to reach 17.0 USD Billion by 2035.</p>

Which type of allergy generates the highest revenue in the market?

<p>Shellfish Allergy generated 10.5 USD Billion in 2024 and is projected to reach 19.4 USD Billion by 2035.</p>

What are the projected revenues for specific IgE testing by 2035?

<p>Specific IgE Testing is expected to generate revenues of 10.2 USD Billion in 2024 and reach 17.0 USD Billion by 2035.</p>

How does the food allergy diagnosis and treatment market's growth compare across different diagnosis methods?

<p>The market for diagnosis methods shows varied growth, with Skin Prick Test projected to grow from 8.1 USD Billion in 2024 to 13.5 USD Billion by 2035.</p>

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. | 1.1 EXECUTIVE SUMMARY
    2. | | 1.1.1 Market Overview
    3. | | 1.1.2 Key Findings
    4. | | 1.1.3 Market Segmentation
    5. | | 1.1.4 Competitive Landscape
    6. | | 1.1.5 Challenges and Opportunities
    7. | | 1.1.6 Future Outlook
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. | 2.1 MARKET INTRODUCTION
    2. | | 2.1.1 Definition
    3. | | 2.1.2 Scope of the study
    4. | | | 2.1.2.1 Research Objective
    5. | | | 2.1.2.2 Assumption
    6. | | | 2.1.2.3 Limitations
    7. | 2.2 RESEARCH METHODOLOGY
    8. | | 2.2.1 Overview
    9. | | 2.2.2 Data Mining
    10. | | 2.2.3 Secondary Research
    11. | | 2.2.4 Primary Research
    12. | | | 2.2.4.1 Primary Interviews and Information Gathering Process
    13. | | | 2.2.4.2 Breakdown of Primary Respondents
    14. | | 2.2.5 Forecasting Model
    15. | | 2.2.6 Market Size Estimation
    16. | | | 2.2.6.1 Bottom-Up Approach
    17. | | | 2.2.6.2 Top-Down Approach
    18. | | 2.2.7 Data Triangulation
    19. | | 2.2.8 Validation
  3. SECTION III: QUALITATIVE ANALYSIS
    1. | 3.1 MARKET DYNAMICS
    2. | | 3.1.1 Overview
    3. | | 3.1.2 Drivers
    4. | | 3.1.3 Restraints
    5. | | 3.1.4 Opportunities
    6. | 3.2 MARKET FACTOR ANALYSIS
    7. | | 3.2.1 Value chain Analysis
    8. | | 3.2.2 Porter's Five Forces Analysis
    9. | | | 3.2.2.1 Bargaining Power of Suppliers
    10. | | | 3.2.2.2 Bargaining Power of Buyers
    11. | | | 3.2.2.3 Threat of New Entrants
    12. | | | 3.2.2.4 Threat of Substitutes
    13. | | | 3.2.2.5 Intensity of Rivalry
    14. | | 3.2.3 COVID-19 Impact Analysis
    15. | | | 3.2.3.1 Market Impact Analysis
    16. | | | 3.2.3.2 Regional Impact
    17. | | | 3.2.3.3 Opportunity and Threat Analysis
  4. SECTION IV: QUANTITATIVE ANALYSIS
    1. | 4.1 Healthcare, BY Application (USD Billion)
    2. | | 4.1.1 Skin Testing
    3. | | 4.1.2 Blood Testing
    4. | | 4.1.3 Oral Food Challenge
    5. | | 4.1.4 Patch Testing
    6. | 4.2 Healthcare, BY End Use (USD Billion)
    7. | | 4.2.1 Hospitals
    8. | | 4.2.2 Diagnostic Laboratories
    9. | | 4.2.3 Home Care Settings
    10. | | 4.2.4 Research Institutions
    11. | 4.3 Healthcare, BY Type of Allergy (USD Billion)
    12. | | 4.3.1 Peanut Allergy
    13. | | 4.3.2 Milk Allergy
    14. | | 4.3.3 Egg Allergy
    15. | | 4.3.4 Shellfish Allergy
    16. | 4.4 Healthcare, BY Diagnosis Method (USD Billion)
    17. | | 4.4.1 Skin Prick Test
    18. | | 4.4.2 Specific IgE Testing
    19. | | 4.4.3 Component Resolved Diagnostics
    20. | | 4.4.4 Elimination Diet
    21. | 4.5 Healthcare, BY Region (USD Billion)
    22. | | 4.5.1 North America
    23. | | | 4.5.1.1 US
    24. | | | 4.5.1.2 Canada
    25. | | 4.5.2 Europe
    26. | | | 4.5.2.1 Germany
    27. | | | 4.5.2.2 UK
    28. | | | 4.5.2.3 France
    29. | | | 4.5.2.4 Russia
    30. | | | 4.5.2.5 Italy
    31. | | | 4.5.2.6 Spain
    32. | | | 4.5.2.7 Rest of Europe
    33. | | 4.5.3 APAC
    34. | | | 4.5.3.1 China
    35. | | | 4.5.3.2 India
    36. | | | 4.5.3.3 Japan
    37. | | | 4.5.3.4 South Korea
    38. | | | 4.5.3.5 Malaysia
    39. | | | 4.5.3.6 Thailand
    40. | | | 4.5.3.7 Indonesia
    41. | | | 4.5.3.8 Rest of APAC
    42. | | 4.5.4 South America
    43. | | | 4.5.4.1 Brazil
    44. | | | 4.5.4.2 Mexico
    45. | | | 4.5.4.3 Argentina
    46. | | | 4.5.4.4 Rest of South America
    47. | | 4.5.5 MEA
    48. | | | 4.5.5.1 GCC Countries
    49. | | | 4.5.5.2 South Africa
    50. | | | 4.5.5.3 Rest of MEA
  5. SECTION V: COMPETITIVE ANALYSIS
    1. | 5.1 Competitive Landscape
    2. | | 5.1.1 Overview
    3. | | 5.1.2 Competitive Analysis
    4. | | 5.1.3 Market share Analysis
    5. | | 5.1.4 Major Growth Strategy in the Healthcare
    6. | | 5.1.5 Competitive Benchmarking
    7. | | 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
    8. | | 5.1.7 Key developments and growth strategies
    9. | | | 5.1.7.1 New Product Launch/Service Deployment
    10. | | | 5.1.7.2 Merger & Acquisitions
    11. | | | 5.1.7.3 Joint Ventures
    12. | | 5.1.8 Major Players Financial Matrix
    13. | | | 5.1.8.1 Sales and Operating Income
    14. | | | 5.1.8.2 Major Players R&D Expenditure. 2023
    15. | 5.2 Company Profiles
    16. | | 5.2.1 Thermo Fisher Scientific (US)
    17. | | | 5.2.1.1 Financial Overview
    18. | | | 5.2.1.2 Products Offered
    19. | | | 5.2.1.3 Key Developments
    20. | | | 5.2.1.4 SWOT Analysis
    21. | | | 5.2.1.5 Key Strategies
    22. | | 5.2.2 Abbott Laboratories (US)
    23. | | | 5.2.2.1 Financial Overview
    24. | | | 5.2.2.2 Products Offered
    25. | | | 5.2.2.3 Key Developments
    26. | | | 5.2.2.4 SWOT Analysis
    27. | | | 5.2.2.5 Key Strategies
    28. | | 5.2.3 Danone (FR)
    29. | | | 5.2.3.1 Financial Overview
    30. | | | 5.2.3.2 Products Offered
    31. | | | 5.2.3.3 Key Developments
    32. | | | 5.2.3.4 SWOT Analysis
    33. | | | 5.2.3.5 Key Strategies
    34. | | 5.2.4 Nestle (CH)
    35. | | | 5.2.4.1 Financial Overview
    36. | | | 5.2.4.2 Products Offered
    37. | | | 5.2.4.3 Key Developments
    38. | | | 5.2.4.4 SWOT Analysis
    39. | | | 5.2.4.5 Key Strategies
    40. | | 5.2.5 Bayer AG (DE)
    41. | | | 5.2.5.1 Financial Overview
    42. | | | 5.2.5.2 Products Offered
    43. | | | 5.2.5.3 Key Developments
    44. | | | 5.2.5.4 SWOT Analysis
    45. | | | 5.2.5.5 Key Strategies
    46. | | 5.2.6 Mylan N.V. (US)
    47. | | | 5.2.6.1 Financial Overview
    48. | | | 5.2.6.2 Products Offered
    49. | | | 5.2.6.3 Key Developments
    50. | | | 5.2.6.4 SWOT Analysis
    51. | | | 5.2.6.5 Key Strategies
    52. | | 5.2.7 Aimmune Therapeutics (US)
    53. | | | 5.2.7.1 Financial Overview
    54. | | | 5.2.7.2 Products Offered
    55. | | | 5.2.7.3 Key Developments
    56. | | | 5.2.7.4 SWOT Analysis
    57. | | | 5.2.7.5 Key Strategies
    58. | | 5.2.8 Allergan (IE)
    59. | | | 5.2.8.1 Financial Overview
    60. | | | 5.2.8.2 Products Offered
    61. | | | 5.2.8.3 Key Developments
    62. | | | 5.2.8.4 SWOT Analysis
    63. | | | 5.2.8.5 Key Strategies
    64. | | 5.2.9 Horizon Therapeutics (IE)
    65. | | | 5.2.9.1 Financial Overview
    66. | | | 5.2.9.2 Products Offered
    67. | | | 5.2.9.3 Key Developments
    68. | | | 5.2.9.4 SWOT Analysis
    69. | | | 5.2.9.5 Key Strategies
    70. | 5.3 Appendix
    71. | | 5.3.1 References
    72. | | 5.3.2 Related Reports
  6. LIST OF FIGURES
    1. | 6.1 MARKET SYNOPSIS
    2. | 6.2 NORTH AMERICA MARKET ANALYSIS
    3. | 6.3 US MARKET ANALYSIS BY APPLICATION
    4. | 6.4 US MARKET ANALYSIS BY END USE
    5. | 6.5 US MARKET ANALYSIS BY TYPE OF ALLERGY
    6. | 6.6 US MARKET ANALYSIS BY DIAGNOSIS METHOD
    7. | 6.7 CANADA MARKET ANALYSIS BY APPLICATION
    8. | 6.8 CANADA MARKET ANALYSIS BY END USE
    9. | 6.9 CANADA MARKET ANALYSIS BY TYPE OF ALLERGY
    10. | 6.10 CANADA MARKET ANALYSIS BY DIAGNOSIS METHOD
    11. | 6.11 EUROPE MARKET ANALYSIS
    12. | 6.12 GERMANY MARKET ANALYSIS BY APPLICATION
    13. | 6.13 GERMANY MARKET ANALYSIS BY END USE
    14. | 6.14 GERMANY MARKET ANALYSIS BY TYPE OF ALLERGY
    15. | 6.15 GERMANY MARKET ANALYSIS BY DIAGNOSIS METHOD
    16. | 6.16 UK MARKET ANALYSIS BY APPLICATION
    17. | 6.17 UK MARKET ANALYSIS BY END USE
    18. | 6.18 UK MARKET ANALYSIS BY TYPE OF ALLERGY
    19. | 6.19 UK MARKET ANALYSIS BY DIAGNOSIS METHOD
    20. | 6.20 FRANCE MARKET ANALYSIS BY APPLICATION
    21. | 6.21 FRANCE MARKET ANALYSIS BY END USE
    22. | 6.22 FRANCE MARKET ANALYSIS BY TYPE OF ALLERGY
    23. | 6.23 FRANCE MARKET ANALYSIS BY DIAGNOSIS METHOD
    24. | 6.24 RUSSIA MARKET ANALYSIS BY APPLICATION
    25. | 6.25 RUSSIA MARKET ANALYSIS BY END USE
    26. | 6.26 RUSSIA MARKET ANALYSIS BY TYPE OF ALLERGY
    27. | 6.27 RUSSIA MARKET ANALYSIS BY DIAGNOSIS METHOD
    28. | 6.28 ITALY MARKET ANALYSIS BY APPLICATION
    29. | 6.29 ITALY MARKET ANALYSIS BY END USE
    30. | 6.30 ITALY MARKET ANALYSIS BY TYPE OF ALLERGY
    31. | 6.31 ITALY MARKET ANALYSIS BY DIAGNOSIS METHOD
    32. | 6.32 SPAIN MARKET ANALYSIS BY APPLICATION
    33. | 6.33 SPAIN MARKET ANALYSIS BY END USE
    34. | 6.34 SPAIN MARKET ANALYSIS BY TYPE OF ALLERGY
    35. | 6.35 SPAIN MARKET ANALYSIS BY DIAGNOSIS METHOD
    36. | 6.36 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
    37. | 6.37 REST OF EUROPE MARKET ANALYSIS BY END USE
    38. | 6.38 REST OF EUROPE MARKET ANALYSIS BY TYPE OF ALLERGY
    39. | 6.39 REST OF EUROPE MARKET ANALYSIS BY DIAGNOSIS METHOD
    40. | 6.40 APAC MARKET ANALYSIS
    41. | 6.41 CHINA MARKET ANALYSIS BY APPLICATION
    42. | 6.42 CHINA MARKET ANALYSIS BY END USE
    43. | 6.43 CHINA MARKET ANALYSIS BY TYPE OF ALLERGY
    44. | 6.44 CHINA MARKET ANALYSIS BY DIAGNOSIS METHOD
    45. | 6.45 INDIA MARKET ANALYSIS BY APPLICATION
    46. | 6.46 INDIA MARKET ANALYSIS BY END USE
    47. | 6.47 INDIA MARKET ANALYSIS BY TYPE OF ALLERGY
    48. | 6.48 INDIA MARKET ANALYSIS BY DIAGNOSIS METHOD
    49. | 6.49 JAPAN MARKET ANALYSIS BY APPLICATION
    50. | 6.50 JAPAN MARKET ANALYSIS BY END USE
    51. | 6.51 JAPAN MARKET ANALYSIS BY TYPE OF ALLERGY
    52. | 6.52 JAPAN MARKET ANALYSIS BY DIAGNOSIS METHOD
    53. | 6.53 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
    54. | 6.54 SOUTH KOREA MARKET ANALYSIS BY END USE
    55. | 6.55 SOUTH KOREA MARKET ANALYSIS BY TYPE OF ALLERGY
    56. | 6.56 SOUTH KOREA MARKET ANALYSIS BY DIAGNOSIS METHOD
    57. | 6.57 MALAYSIA MARKET ANALYSIS BY APPLICATION
    58. | 6.58 MALAYSIA MARKET ANALYSIS BY END USE
    59. | 6.59 MALAYSIA MARKET ANALYSIS BY TYPE OF ALLERGY
    60. | 6.60 MALAYSIA MARKET ANALYSIS BY DIAGNOSIS METHOD
    61. | 6.61 THAILAND MARKET ANALYSIS BY APPLICATION
    62. | 6.62 THAILAND MARKET ANALYSIS BY END USE
    63. | 6.63 THAILAND MARKET ANALYSIS BY TYPE OF ALLERGY
    64. | 6.64 THAILAND MARKET ANALYSIS BY DIAGNOSIS METHOD
    65. | 6.65 INDONESIA MARKET ANALYSIS BY APPLICATION
    66. | 6.66 INDONESIA MARKET ANALYSIS BY END USE
    67. | 6.67 INDONESIA MARKET ANALYSIS BY TYPE OF ALLERGY
    68. | 6.68 INDONESIA MARKET ANALYSIS BY DIAGNOSIS METHOD
    69. | 6.69 REST OF APAC MARKET ANALYSIS BY APPLICATION
    70. | 6.70 REST OF APAC MARKET ANALYSIS BY END USE
    71. | 6.71 REST OF APAC MARKET ANALYSIS BY TYPE OF ALLERGY
    72. | 6.72 REST OF APAC MARKET ANALYSIS BY DIAGNOSIS METHOD
    73. | 6.73 SOUTH AMERICA MARKET ANALYSIS
    74. | 6.74 BRAZIL MARKET ANALYSIS BY APPLICATION
    75. | 6.75 BRAZIL MARKET ANALYSIS BY END USE
    76. | 6.76 BRAZIL MARKET ANALYSIS BY TYPE OF ALLERGY
    77. | 6.77 BRAZIL MARKET ANALYSIS BY DIAGNOSIS METHOD
    78. | 6.78 MEXICO MARKET ANALYSIS BY APPLICATION
    79. | 6.79 MEXICO MARKET ANALYSIS BY END USE
    80. | 6.80 MEXICO MARKET ANALYSIS BY TYPE OF ALLERGY
    81. | 6.81 MEXICO MARKET ANALYSIS BY DIAGNOSIS METHOD
    82. | 6.82 ARGENTINA MARKET ANALYSIS BY APPLICATION
    83. | 6.83 ARGENTINA MARKET ANALYSIS BY END USE
    84. | 6.84 ARGENTINA MARKET ANALYSIS BY TYPE OF ALLERGY
    85. | 6.85 ARGENTINA MARKET ANALYSIS BY DIAGNOSIS METHOD
    86. | 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
    87. | 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE
    88. | 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE OF ALLERGY
    89. | 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY DIAGNOSIS METHOD
    90. | 6.90 MEA MARKET ANALYSIS
    91. | 6.91 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
    92. | 6.92 GCC COUNTRIES MARKET ANALYSIS BY END USE
    93. | 6.93 GCC COUNTRIES MARKET ANALYSIS BY TYPE OF ALLERGY
    94. | 6.94 GCC COUNTRIES MARKET ANALYSIS BY DIAGNOSIS METHOD
    95. | 6.95 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
    96. | 6.96 SOUTH AFRICA MARKET ANALYSIS BY END USE
    97. | 6.97 SOUTH AFRICA MARKET ANALYSIS BY TYPE OF ALLERGY
    98. | 6.98 SOUTH AFRICA MARKET ANALYSIS BY DIAGNOSIS METHOD
    99. | 6.99 REST OF MEA MARKET ANALYSIS BY APPLICATION
    100. | 6.100 REST OF MEA MARKET ANALYSIS BY END USE
    101. | 6.101 REST OF MEA MARKET ANALYSIS BY TYPE OF ALLERGY
    102. | 6.102 REST OF MEA MARKET ANALYSIS BY DIAGNOSIS METHOD
    103. | 6.103 KEY BUYING CRITERIA OF HEALTHCARE
    104. | 6.104 RESEARCH PROCESS OF MRFR
    105. | 6.105 DRO ANALYSIS OF HEALTHCARE
    106. | 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    107. | 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    108. | 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
    109. | 6.109 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    110. | 6.110 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
    111. | 6.111 HEALTHCARE, BY END USE, 2024 (% SHARE)
    112. | 6.112 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion)
    113. | 6.113 HEALTHCARE, BY TYPE OF ALLERGY, 2024 (% SHARE)
    114. | 6.114 HEALTHCARE, BY TYPE OF ALLERGY, 2024 TO 2035 (USD Billion)
    115. | 6.115 HEALTHCARE, BY DIAGNOSIS METHOD, 2024 (% SHARE)
    116. | 6.116 HEALTHCARE, BY DIAGNOSIS METHOD, 2024 TO 2035 (USD Billion)
    117. | 6.117 BENCHMARKING OF MAJOR COMPETITORS
  7. LIST OF TABLES
    1. | 7.1 LIST OF ASSUMPTIONS
    2. | | 7.1.1
    3. | 7.2 North America MARKET SIZE ESTIMATES; FORECAST
    4. | | 7.2.1 BY APPLICATION, 2025-2035 (USD Billion)
    5. | | 7.2.2 BY END USE, 2025-2035 (USD Billion)
    6. | | 7.2.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
    7. | | 7.2.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
    8. | 7.3 US MARKET SIZE ESTIMATES; FORECAST
    9. | | 7.3.1 BY APPLICATION, 2025-2035 (USD Billion)
    10. | | 7.3.2 BY END USE, 2025-2035 (USD Billion)
    11. | | 7.3.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
    12. | | 7.3.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
    13. | 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
    14. | | 7.4.1 BY APPLICATION, 2025-2035 (USD Billion)
    15. | | 7.4.2 BY END USE, 2025-2035 (USD Billion)
    16. | | 7.4.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
    17. | | 7.4.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
    18. | 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
    19. | | 7.5.1 BY APPLICATION, 2025-2035 (USD Billion)
    20. | | 7.5.2 BY END USE, 2025-2035 (USD Billion)
    21. | | 7.5.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
    22. | | 7.5.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
    23. | 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
    24. | | 7.6.1 BY APPLICATION, 2025-2035 (USD Billion)
    25. | | 7.6.2 BY END USE, 2025-2035 (USD Billion)
    26. | | 7.6.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
    27. | | 7.6.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
    28. | 7.7 UK MARKET SIZE ESTIMATES; FORECAST
    29. | | 7.7.1 BY APPLICATION, 2025-2035 (USD Billion)
    30. | | 7.7.2 BY END USE, 2025-2035 (USD Billion)
    31. | | 7.7.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
    32. | | 7.7.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
    33. | 7.8 France MARKET SIZE ESTIMATES; FORECAST
    34. | | 7.8.1 BY APPLICATION, 2025-2035 (USD Billion)
    35. | | 7.8.2 BY END USE, 2025-2035 (USD Billion)
    36. | | 7.8.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
    37. | | 7.8.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
    38. | 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
    39. | | 7.9.1 BY APPLICATION, 2025-2035 (USD Billion)
    40. | | 7.9.2 BY END USE, 2025-2035 (USD Billion)
    41. | | 7.9.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
    42. | | 7.9.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
    43. | 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
    44. | | 7.10.1 BY APPLICATION, 2025-2035 (USD Billion)
    45. | | 7.10.2 BY END USE, 2025-2035 (USD Billion)
    46. | | 7.10.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
    47. | | 7.10.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
    48. | 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
    49. | | 7.11.1 BY APPLICATION, 2025-2035 (USD Billion)
    50. | | 7.11.2 BY END USE, 2025-2035 (USD Billion)
    51. | | 7.11.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
    52. | | 7.11.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
    53. | 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
    54. | | 7.12.1 BY APPLICATION, 2025-2035 (USD Billion)
    55. | | 7.12.2 BY END USE, 2025-2035 (USD Billion)
    56. | | 7.12.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
    57. | | 7.12.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
    58. | 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
    59. | | 7.13.1 BY APPLICATION, 2025-2035 (USD Billion)
    60. | | 7.13.2 BY END USE, 2025-2035 (USD Billion)
    61. | | 7.13.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
    62. | | 7.13.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
    63. | 7.14 China MARKET SIZE ESTIMATES; FORECAST
    64. | | 7.14.1 BY APPLICATION, 2025-2035 (USD Billion)
    65. | | 7.14.2 BY END USE, 2025-2035 (USD Billion)
    66. | | 7.14.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
    67. | | 7.14.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
    68. | 7.15 India MARKET SIZE ESTIMATES; FORECAST
    69. | | 7.15.1 BY APPLICATION, 2025-2035 (USD Billion)
    70. | | 7.15.2 BY END USE, 2025-2035 (USD Billion)
    71. | | 7.15.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
    72. | | 7.15.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
    73. | 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
    74. | | 7.16.1 BY APPLICATION, 2025-2035 (USD Billion)
    75. | | 7.16.2 BY END USE, 2025-2035 (USD Billion)
    76. | | 7.16.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
    77. | | 7.16.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
    78. | 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
    79. | | 7.17.1 BY APPLICATION, 2025-2035 (USD Billion)
    80. | | 7.17.2 BY END USE, 2025-2035 (USD Billion)
    81. | | 7.17.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
    82. | | 7.17.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
    83. | 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
    84. | | 7.18.1 BY APPLICATION, 2025-2035 (USD Billion)
    85. | | 7.18.2 BY END USE, 2025-2035 (USD Billion)
    86. | | 7.18.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
    87. | | 7.18.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
    88. | 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
    89. | | 7.19.1 BY APPLICATION, 2025-2035 (USD Billion)
    90. | | 7.19.2 BY END USE, 2025-2035 (USD Billion)
    91. | | 7.19.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
    92. | | 7.19.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
    93. | 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
    94. | | 7.20.1 BY APPLICATION, 2025-2035 (USD Billion)
    95. | | 7.20.2 BY END USE, 2025-2035 (USD Billion)
    96. | | 7.20.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
    97. | | 7.20.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
    98. | 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
    99. | | 7.21.1 BY APPLICATION, 2025-2035 (USD Billion)
    100. | | 7.21.2 BY END USE, 2025-2035 (USD Billion)
    101. | | 7.21.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
    102. | | 7.21.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
    103. | 7.22 South America MARKET SIZE ESTIMATES; FORECAST
    104. | | 7.22.1 BY APPLICATION, 2025-2035 (USD Billion)
    105. | | 7.22.2 BY END USE, 2025-2035 (USD Billion)
    106. | | 7.22.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
    107. | | 7.22.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
    108. | 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
    109. | | 7.23.1 BY APPLICATION, 2025-2035 (USD Billion)
    110. | | 7.23.2 BY END USE, 2025-2035 (USD Billion)
    111. | | 7.23.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
    112. | | 7.23.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
    113. | 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
    114. | | 7.24.1 BY APPLICATION, 2025-2035 (USD Billion)
    115. | | 7.24.2 BY END USE, 2025-2035 (USD Billion)
    116. | | 7.24.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
    117. | | 7.24.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
    118. | 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
    119. | | 7.25.1 BY APPLICATION, 2025-2035 (USD Billion)
    120. | | 7.25.2 BY END USE, 2025-2035 (USD Billion)
    121. | | 7.25.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
    122. | | 7.25.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
    123. | 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
    124. | | 7.26.1 BY APPLICATION, 2025-2035 (USD Billion)
    125. | | 7.26.2 BY END USE, 2025-2035 (USD Billion)
    126. | | 7.26.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
    127. | | 7.26.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
    128. | 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
    129. | | 7.27.1 BY APPLICATION, 2025-2035 (USD Billion)
    130. | | 7.27.2 BY END USE, 2025-2035 (USD Billion)
    131. | | 7.27.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
    132. | | 7.27.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
    133. | 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
    134. | | 7.28.1 BY APPLICATION, 2025-2035 (USD Billion)
    135. | | 7.28.2 BY END USE, 2025-2035 (USD Billion)
    136. | | 7.28.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
    137. | | 7.28.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
    138. | 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
    139. | | 7.29.1 BY APPLICATION, 2025-2035 (USD Billion)
    140. | | 7.29.2 BY END USE, 2025-2035 (USD Billion)
    141. | | 7.29.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
    142. | | 7.29.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
    143. | 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
    144. | | 7.30.1 BY APPLICATION, 2025-2035 (USD Billion)
    145. | | 7.30.2 BY END USE, 2025-2035 (USD Billion)
    146. | | 7.30.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
    147. | | 7.30.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
    148. | 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    149. | | 7.31.1
    150. | 7.32 ACQUISITION/PARTNERSHIP
    151. | | 7.32.1

Healthcare Market Segmentation

Healthcare By Application (USD Billion, 2025-2035)

  • Skin Testing
  • Blood Testing
  • Oral Food Challenge
  • Patch Testing

Healthcare By End Use (USD Billion, 2025-2035)

  • Hospitals
  • Diagnostic Laboratories
  • Home Care Settings
  • Research Institutions

Healthcare By Type of Allergy (USD Billion, 2025-2035)

  • Peanut Allergy
  • Milk Allergy
  • Egg Allergy
  • Shellfish Allergy

Healthcare By Diagnosis Method (USD Billion, 2025-2035)

  • Skin Prick Test
  • Specific IgE Testing
  • Component Resolved Diagnostics
  • Elimination Diet
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓